Simon C. Satchell
Bristol, ENG BS13NY, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 86 publications
Heparanase inhibition prevents glycocalyx damage and albuminuria in experimental minimal change disease.
Journal: Clinical and translational medicine
Published: January 30, 2026
The glomerular endothelial glycocalyx as a therapeutic target in proteinuric kidney disease.
Journal: Nature reviews. Nephrology
Published: October 22, 2025
Mitochondrial activity promotes neutrophil degranulation and endothelial dysfunction in systemic infections.
Journal: EMBO molecular medicine
Published: October 10, 2025
Podocyte-directed VEGFC gene therapy prevents increased glomerular permeability and glycocalyx damage in experimental type 1 diabetes.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 14, 2025
Autoantibodies reactive with glomerular endothelial cells and podocytes in patients with membranous nephropathy.
Journal: Journal of translational autoimmunity
Published: June 18, 2025
Endothelial-erythrocyte glycocalyx exchange enables liquid biopsies of endothelial function.
Journal: Nature communications
Published: March 03, 2025
Matrix metalloproteinase-9 mediates endothelial glycocalyx degradation and correlates with severity of hemorrhagic fever with renal syndrome.
Journal: iScience
Published: February 19, 2025
Biosynthesis, characterisation and biocompatibility of a unique and elastomeric medium chain-length polyhydroxyalkanoates for kidney glomerular tissue engineering.
Journal: Materials today. Bio
Published: February 05, 2025
Glomerular ultrastructural change and vascular endothelial growth factor-A expression in diabetic cats.
Journal: The Journal of small animal practice
Published: November 19, 2024
Last Updated: 09/26/2026